Osiris Therapeutics

Osiris Therapeutics
Company type	Public
Traded as	Nasdaq: OSIR
Industry	Pharmaceuticals
Headquarters	Columbia, Maryland, United States
Key people	Dwayne Montgomery(CEO), Greg Law (CFO), Frank Czworka (COO), Alla Danilkovitch (CSO), Jon Hopper (CMO)
Products	Grafix, Cartiform, BIO4,
Website	osiris.com

Osiris Therapeutics, Inc., based in Columbia, Maryland, is a company researching, developing and marketing regenerative medicine products. One of its products, Stromagen was used to treat breast cancer in clinical trials.^[1]

References

^ "Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. May 11, 2017. Retrieved May 11, 2017. This article incorporates text from this source, which is in the public domain.

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

[1] "Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. May 11, 2017. Retrieved May 11, 2017. This article incorporates text from this source, which is in the public domain.

[1]